Effect of FOLFOX chemotherapy on gene expression and on the FDG kinetics in a human colorectal cancer cell line

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Strauss, LG
Koczan, D
Hoffend, J
Thiesen, HJ
Haberkorn, U
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany
[2] Univ Rostock, Inst Immunol, D-2500 Rostock 1, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [1] Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
    Strauss, Ludwig G.
    Hoffend, Johannes
    Koczan, Dirk
    Pan, Leyun
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (08) : 1226 - 1234
  • [2] Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
    Ludwig G. Strauss
    Johannes Hoffend
    Dirk Koczan
    Leyun Pan
    Uwe Haberkorn
    Antonia Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1226 - 1234
  • [3] Effect of FOLFOX6 chemotherapy on serum VEGF expression in advanced colorectal cancer patients
    Kong Ying
    Yang Chong
    Wang Wei
    Dong Bing
    Su Yanyan
    Yi Xuefeng
    Wan Wei
    Li Ke
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (02): : 177 - 182
  • [4] FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer
    Aparicio, Jorge
    Fernandez-Martos, Carlos
    Vicent, Jose M.
    Maestu, Inmaculada
    Llorca, Cristina
    Busquier, Isabel
    Campos, Jan M.
    Perez-Enguix, Daniel
    Balcells, Miquel
    CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 263 - 267
  • [5] Therapy monitoring with FDG PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Strauss, L
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 23P
  • [6] The identification and characterization of FOLFOX chemotherapy resistant cell lineages in colorectal cancer organoids
    Morris, Julia M.
    Thorne, Curtis A.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Evaluation of early effects of chemotherapy using a human colorectal cancer cell line
    Strauss, L. G.
    Koczan, D.
    Hoffend, J.
    Haberkorn, U.
    Pan, L.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S36 - S36
  • [8] Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Rudi, J
    Strauss, LG
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 113P - 113P
  • [9] Response to FOLFOX chemotherapy in patients with colorectal cancer according to RRM2 expression
    Yan, Chongxian
    Fang, Zejun
    Liu, Hong
    Shao, Jianli
    Wang, Anhua
    Sun, Long
    Zhu, Zhihua
    Luo, Shuchai
    Chen, Xiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21970 - 21978
  • [10] Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Burger, C
    Rühl, A
    Irngartinger, G
    Stremmel, W
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (09) : 1480 - 1487
12345